A series of substituted ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5- (1-methyl-1H-indol-3-yl)-4-[(1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylates were prepared in excellent yields (82-98%) by one-pot reactions between β-dicarbonyl compounds 12a–e and 1,2-diaza-1,3-diene (DD) 13. Derivatives 10a,c–e, deazaanalogues of the bis-indole alkaloid topsentin, screened by the National Cancer Institute (Bethesda, MD, USA) in the in vitro one dose primary anticancer assay against a panel of about 60 human tumor cell lines, showed no significant activity, with the exception of compound 9e, which showed moderate activity against the HOP-92 cell line of the non small cell lung cancer sub-panel and the SNB-75 cell line of the CNS sub-panel.
通过 β-二羰基化合物 12a-e 和 1,2-二氮杂-1,3-二烯 (DD) 13 的一锅反应,制备了一系列取代的 1-[(叔丁氧羰基)
氨基]-2-甲基-5-(1-甲基-1H-
吲哚-3-基)-4-[(1-甲基-1H-
吲哚-3-基)羰基]-1H-
吡咯-3-
羧酸乙酯,收率极高(82-98%)。衍
生物 10a、c-e 是双
吲哚生物碱托普生丁的脱氮类似物,经美国国家癌症研究所(Bethesda, MD, U
SA)在体外一剂一级抗癌试验中对约 60 种人类肿瘤
细胞系进行筛选,结果显示,除化合物 9e 对非小细胞肺癌亚组的 HOP-92
细胞系和中枢神经系统亚组的 SNB-75
细胞系有中等活性外,其余化合物均无明显活性。